Hospital & Healthcare Management December 24, 2025
ZOLL, a medical device and related software solutions maker, has gone ahead and introduced its next-gen LifeVest wearable cardioverter defibrillator – WCD in the US.
The latest device, apparently, is the fifth LifeVest WCD, which has secured the Food and Drug Administration – FDA approval.
It is indeed compatible with the recently released next-gen LifeVest garment.
ZOLL went on to note that the device is expected to offer safe and effective therapy for those who are at risk of sudden cardiac death, with high levels of patient compliance, which is supported by data coming from real-world usage and also peer-reviewed publications.
The last three versions have had integrated response buttons within the monitor, enabling the conscious patients to delay the...
Today's Sponsors
Today's Sponsor